Arcus Biosciences RCUS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$128M-14.3% | -$106M-12.8% | -$135M-46.7% | $0+100% | -$112M-2,700% | ||
| $2M-33.3% | $3M0.0% | $2M0.0% | $2M0.0% | $3M0.0% | ||
| $19M+18.8% | $15M-11.8% | $14M-26.3% | $15M-25.0% | $16M-20.0% | ||
| -$3M-200% | $0-100% | $13M+1,400% | $8M— | $3M+400% | ||
| $3M— | $0+100% | -$6M-500% | $1M+110% | $0+100% | ||
| -$16M+5.9% | —— | $24M+9.1% | —— | -$17M-41.7% | ||
| $1M— | —— | $2M+100% | $0-100% | $0— | ||
| -$17M+39.3% | -$26M+38.1% | -$26M— | -$160M-310% | -$28M+33.3% | ||
| $2M0.0% | $2M0.0% | $2M+100% | $1M-50.0% | $2M0.0% | ||
| -$138M-4.5% | -$120M-20.0% | -$97M— | -$133M-41.5% | -$132M-6,500% | ||
| $0-100% | $1M0.0% | —— | —— | $1M-75.0% | ||
| $114M+256% | —— | $79M+372% | $137M— | $32M+119% | ||
| $0-100% | $279M— | $8M— | $0— | $142M-37.7% | ||
| $3M-97.9% | $286M— | $8M-83.3% | $52M+2,500% | $142M-38.0% | ||
| -$21M-150% | —— | —— | $56M— | $42M-27.6% | ||
| —— | $1.75M+600% | $1.75M+600% | $1.75M+600% | $1.75M+600% | ||
| $3M-25.0% | $3M-50.0% | $3M-50.0% | $3M-57.1% | $4M-33.3% | ||
| -$8M-60.0% | —— | -$4M+66.7% | —— | -$5M+61.5% | ||
| -$16M+5.9% | —— | $24M+9.1% | —— | -$17M-41.7% | ||
| $2M0.0% | $2M0.0% | $2M+100% | $1M-50.0% | $2M0.0% | ||
| $3M— | $7M+133% | $0-100% | $3M0.0% | $0-100% | ||
| -$17M+39.3% | -$26M+38.1% | -$26M— | -$160M-310% | -$28M+33.3% | ||
| -$138M-3.8% | -$121M-19.8% | -$97M— | -$133M-41.5% | -$133M-2,117% | ||
| -$138M-3.8% | -$121M-19.8% | -$97M— | -$133M-41.5% | -$133M-2,117% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Arcus Biosciences's cash flow data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.